AU2008201695B2 - Compacted implantable medical devices and method of compacting such devices - Google Patents
Compacted implantable medical devices and method of compacting such devices Download PDFInfo
- Publication number
- AU2008201695B2 AU2008201695B2 AU2008201695A AU2008201695A AU2008201695B2 AU 2008201695 B2 AU2008201695 B2 AU 2008201695B2 AU 2008201695 A AU2008201695 A AU 2008201695A AU 2008201695 A AU2008201695 A AU 2008201695A AU 2008201695 B2 AU2008201695 B2 AU 2008201695B2
- Authority
- AU
- Australia
- Prior art keywords
- capture tube
- stent
- compacted
- tube
- profile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title description 53
- 230000002829 reductive effect Effects 0.000 description 34
- 238000005056 compaction Methods 0.000 description 30
- 230000008569 process Effects 0.000 description 25
- 241000894007 species Species 0.000 description 18
- 239000000463 material Substances 0.000 description 14
- 230000009467 reduction Effects 0.000 description 12
- 238000012546 transfer Methods 0.000 description 9
- 230000000452 restraining effect Effects 0.000 description 8
- 238000002788 crimping Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 6
- 239000010963 304 stainless steel Substances 0.000 description 5
- JCYZMTMYPZHVBF-UHFFFAOYSA-N Melarsoprol Chemical compound NC1=NC(N)=NC(NC=2C=CC(=CC=2)[As]2SC(CO)CS2)=N1 JCYZMTMYPZHVBF-UHFFFAOYSA-N 0.000 description 5
- 229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 238000002399 angioplasty Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001263 D-2 tool steel Inorganic materials 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000009958 sewing Methods 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- 229910000744 A-2 tool steel Inorganic materials 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000033999 Device damage Diseases 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000557624 Nucifraga Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910001315 Tool steel Inorganic materials 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 210000001154 skull base Anatomy 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000013151 thrombectomy Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Description
AUSTRALIA Patents Act 1990 COMPLETE SPECIFICATION Standard Patent Applicant(s) GORE ENTERPRISE HOLDINGS, INC. Invention Title: COMPACTED IMPLANTABLE MEDICAL DEVICES AND METHOD OF COMPACTING SUCH DEVICES The following statement is a full description of this invention, including the best method for performing it known to me/us: P57541 AU I PatSeFiling Aplication 2008.4-1 doc (M) 2 TITLE OF THE INVENTION COMPACTED IMPLANTABLE MEDICAL DEVICES AND METHOD OF COMPACTING SUCH DEVICES 5 BACKGROUND OF THE INVENTION 1. Field of the Invention 10 The present invention relates to medical devices that are delivered into patients by catheters using minimally invasive procedures and methods of compacting such devices. This application claims divisional status from Australian Patent Application No. 2004207461, the disclosure of which is incorporated herein by reference. 15 2. Description of Related Art Arteriosclerosis affects a significant portion of the population. The progressive nature of the disease can result in severe vessel stenosis (narrowing) and ischemic 20 conditions distal to the stenosis. Although conventional surgical interventions have proven highly effective at treating such conditions, in many cases associated procedural morbidity and mortality has driven the development of alternate "minimally invasive" therapies. These therapies are particularly useful when a lesion to be treated is deep within the body, such as in aortic and cardiac vessels or within the skull base 25 (such as, a carotid artery or deep neuro-vasculature). These minimally invasive techniques have enjoyed increasing success and acceptance in the treatment of several vascular diseases including aneurysmal and occlusive disease. In a typical minimally invasive procedure, upon gaining percutaneous access to the patient's vascular system, a guidewire is introduced and guided under fluoroscopic 30 visualization to the intended site of therapy. The guidewire then serves as "rail" onto which other subsequent devices are guided through the vessels to the site. A typical occlusive lesion may require pre-dilation (e.g., PTA or PTCA) and the placement of an endovascular device (such as a stent or stent-graft). This device may then permanently reside within the lumen of the vessel. All components for these 35 procedures are delivered within the vessel (i.e., "endoluminally") and actuated remotely N:\Melbourne\Caes\Patent\57000-57999\P57541.AU.1\Specia\PS7541.AU.1 apeci as filed.doc 16/04/08 3 from outside of the body. Since open surgery is not required, these procedures are considered "minimally invasive." For the purposes of the following description, endovascular devices may be classified in two general categories: (1) plastically deformable (e.g., balloon 5 expandable); and (2) self-expanding. Plastically deformable devices are generally deployed by deforming the device at the site of therapy, usually by internal pressure such as inflation of an angioplasty balloon. Devices of this type are generally made of a ductile bio-acceptable material that provides little recoil after dilation. A major advantage of the plastically deformable 10 device is obviating the need for incorporating a restraining device into the delivery system since balloon inflation is all that is needed for proper deployment. Self-expanding devices, in contrast, are designed to spontaneously deploy in situ once they are released from a constrained profile. They are generally made from some type of elastic, super-elastic, and/or shape memory metal or polymer. 15 Advantages of this type of device are: 1) self-deployment obviates the need for high pressure ballooning at the therapy site; 2) clinical application of self-expanding devices has demonstrated a significant increase in minimum lumen diameter as compared to balloon expandable devices; and 3) super-elastic, pseudo-elastic, and shape memory alloys provide a high degree of compliance and will maintain their expanded. profiles 20 despite subsequent mechanical deformation (such as forces that might be encountered in an accident or other pressure applied through a patient's skin). Both device categories share a common requirement that they must be introduced to the body from an access site remote to the actual therapy site. As a result, they must be inserted in a first small "introductory" configuration, guided at this 25 introductory profile through a patient's vasculature, and deployed through an actuation mechanism to achieve a second "functional" configuration. Many techniques have been developed to configure endovascular devices at a small introductory profile in preparation for insertion to the body. These techniques vary depending upon the category of the individual device. 30 In the instance of plastically deformable devices, the device may only need to be mechanically crimped onto a balloon prior to insertion to the body. Since this device is made of substantially non-recoiling material, the device, once crimped onto the balloon, will be readily retained on the balloon while being guided to the lesion site. Although crimping may be done by hand, manual techniques are often 35 unsatisfactory due to non-uniform pressure applied to the crimped device. This can N:\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specie\P57541.AU.1 speci as filed.doc 16/04/08 4 lead to non-uniform device expansion and increased variability in clinical performance. As a result, a number of devices and processes have been developed to reliably and consistently crimp plastically deformable devices onto, or into, a delivery system. US Patent 5,920,975 to Morales describes a tool that winds a spring-like 5 element around a plastically deformable device while it is mounted upon a delivery balloon. As the spring is tightened, pressure is applied to the device intending to crimp it onto the balloon. EP Patent Application 630,623 to Williams et al. describes two methods to reduce the cross section of a device. In one embodiment, a plastically deformable 10 device is mounted upon a delivery balloon and placed between reciprocating flat plates. The flat plates act to roll the device while reducing its cross sectional profile. The additions of force and size gauges, as well as inherent consistency of the machine, make this an improvement over the manual crimping technique of rolling the device between fingers. 15 In another embodiment of Williams et al., a plastically deformable device is mounted on a delivery balloon and then inserted into a chamber. This chamber is lined with a sealed, distensible bladder that, upon inflation, applies a circumferential crushing force to the device. This crushing force is intended to reduce the device profile and securely mount the device on the balloon. 20 US Patent 6,309,383 to Campbell et al. describes a crimping tool that resembles a hand-held nutcracker or set of pliers. A plastically deformable device is mounted on a delivery balloon and inserted into an orifice in the apparatus. The crimping tool is squeezed to apply pressure to the outside of the device to radially compact the device onto the balloon. 25 EP Patent Application 903,122 to Morales describes a crimping tool that uses a set of jaws to radially constrict a plastically deformable device onto a delivery balloon. The segmented jaws are hinged on one end to allow them to open and accept a device and its balloon delivery system. Once the device is inside, a collar is slid over the outer surface of the jaws. Pressure applied against the jaws by the collar causes them 30 to close, thereby crushing the device onto the balloon. In the instance of self-expanding devices, the diametrical size of the device needs to be reduced to an "introductory" profile and held in place by some constraint. This is generally a more complex procedure than compacting a plastically deformable 35 device since a steady constraint must be applied to the compacted device from its N:\Melbourne\Casea\Patent\57000-57999\P57541.AU.1\Speci\P57541.AU.1 apeci as filed-doc 16/04/08 5 initial compaction to its ultimate deployment. This is typically accomplished using a tool or machine to reduce the device profile, and then the device is transferred in its compacted state to a restraining sheath, catheter, or other constraining means. The constraining means is kept actively engaged up to the time of deployment at the 5 treatment site. US Patent 6,096,027 to Layne describes an apparatus for crushing and loading a self-expanding device. This device utilizes a bag surrounding the device that is pulled through a tapered die (funnel). As the device moves through the funnel its cross sectional profile is reduced. Upon exiting the die, the bag is removed and the device is 10 captured in a restraining tube or sheath. US Patent 5,928,258 to Kahn et al. describes an apparatus for crushing and loading a self-expanding device that utilizes a cylindrical cartridge for receiving the device and another implement for transferring the device into a delivery sheath. The device is pulled into the first cartridge, and then a plunger mechanism is used to 15 transfer it to an awaiting delivery sheath or catheter. US Patent 5,873,906 to Lau et al. describes a method of "folding" a self expanding device which entails flattening and rolling the device into a "jelly roll" configuration. The device is then restrained in this "introductory" profile through the use of a fiber based constraining mechanism, and applied to a delivery system. A 20 series of fibers are likewise used to constrain a self-expanding device in US Patent 6,224,627 to Armstrong et al. Further improvements in compacting self-expanding devices to a minimal introductory profile are disclosed in International Publication No. WO 00/42948 to Vonesh et al., which describes unique fluted funnel designs that allow self-expanding 25 devices to be simultaneously folded and compacted through a funnel to a very low introductory profile. While all of these prior devices may work well for their intended purposes, it is believed that further significant reductions in introductory profiles may still be possible. Two competing design parameters confront an implantable device designer in 30 maximizing compaction of a device. In addition to having sufficient structural integrity to work for its intended purpose, a compacted implantable device design must balance: (1) the need to limit the amount of material comprising the implantable device so as to have less material to compact; and (2) the need to have a fairly robust implantable device that can withstand the considerable forces encountered in achieving extremely 35 compact dimensions. While a device formed from thinner materials has less material N:\Melbourne\Cases\Patent\57000-57999\PS7541.AU.1\Specia\PS7541.AU.1 speci as filed.doc 16/04/08 6 to compact, such a device may not withstand the forces required to reach the smallest possible compacted state. In contrast, a robust implantable device that can be withstand aggressive "mashing" to smaller dimensions generally has too much material to achieve a small enough profile. This conflict between minimizing device bulk while 5 maximizing device robustness is most clearly confronted when compacting a self expanding implantable device through a funnel. It is believed that the most effective means currently known for compacting a self-expanding device is to pull the device down to a compact size through one or more funnel devices, and particularly through a fluted funnel device. This process is very 10 effective at achieving a small compacted size while imparting minimal damage to the implantable device. Unfortunately, the process of pulling a device through a funnel is limited by the robustness of the implantable device. In order to compact a device in a funnel, the device is attached to tether lines or similar means and then actuated through the funnel. This applies a number of forces to the implantable device, 15 including the force necessary to compact the device as well as the friction forces applied by the funnel and any subsequent restraining means as the device is squeezed through these apparatuses. A thin, lightweight device has the advantage of having minimum material to compact, but such devices tend to pull apart as they are pulled through tight funnels to very small compacted dimensions. More robust devices that 20 can withstand such extreme pulling forces can be provided, but these devices are by necessity bulkier and therefore limited in their ultimate compactability. It is accordingly a purpose of the present invention to provide an improved method for compacting an implantable device that can achieve a highly compacted introductory profile. 25 It is a further purpose of the present invention to provide such a method for compacting that does not damage the device in the process of compaction and without the need to have an overly bulky implantable device. It is still a further purpose of the present invention to provide an implantable device that has a very low delivery profile that is smaller than a profile that can be 30 achieved by pulling the device through a funnel. These and other purposes of the present invention will become evident from review of the following description. N:\Melbourne\Casee\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08 7 SUMMARY OF THE INVENTION The present invention provides a capture tube and indwelling stent assembly, the stent being self-expanding to an expanded diameter and having a 5 longitudinal tensile strength, and the capture tube being deformable and having an expanded diameter that is less than the expanded diameter of the stent, wherein the assembly can be swaged to a compacted diameter that is less than the expanded diameter of the capture tube, 10 wherein, when the assembly is compacted to the compacted diameter, the stent can be removed from the capture tube by application of a tensile force on the stent that is less than the longitudinal tensile strength, and wherein the longitudinal tensile strength of the stent is less than the tensile force required to directly swage the stent to the compacted diameter. 15 The present invention provides unique implantable devices that have extremely small introductory profiles, and particularly interventional devices, and methods for achieving such small introductory profiles. The small profiles achieved with the present invention are possible by "decoupling" the forces required to pull an implantable device through a funnel into a retaining device from the forces required to compact the device 20 fully to its introductory profile. For example, forces can be decoupled in the present invention by pulling an implantable device from a fully enlarged profile through a funnel and into a capture tube at an intermediate device profile. The intermediate profile should be one that limits the compaction and friction forces required to compact and capture the device to less than the longitudinal strength of the device. Once placed in 25 the capture tube at the intermediate profile, the capture tube and device are then compressed further to a final delivery profile by swaging the capture tube. The process of the present invention protects the integrity of the implantable device without requiring the implantable device to be more "robust" in order to withstand the cumulative compaction and friction forces of transforming it from its fully 30 enlarged profile to its fully compacted profile. In one embodiment the present invention comprises a method of reducing the cross sectional dimension of a medical device by providing a medical device having an initial cross sectional profile and a restraining member adapted to receive the medical device at a reduced profile. The profile of the medical device is first reduced, such as 35 using a funnel or similar reduction device, to an intermediate cross sectional profile and 874926_2 (GHMatters) 16/04/08 7a then placed at this intermediate profile into the restraining member. Radial compressive force is then applied to the restraining member to further reduce the cross sectional profile of the medical device to a fully compacted profile suitable for delivery into a patient. 5 The present invention further provides a self-expanding stent with an extremely small introductory profile. The stent is one having a longitudinal tensile strength, an enlarged diameter, and a compacted diameter. Since it is created through the de coupling process of the present invention, the compacted diameter of said stent is smaller than a diameter that could be obtained using a funnel alone to reduce the stent 10 from its enlarged diameter to its compacted diameter. 874926 2 (GHMatters) 16/04/08 8 DESCRIPTION OF THE DRAWINGS The operation of the present invention should become apparent from the following description when considered in conjunction with the accompanying drawings, 5 in which: Figure 1 is a side view of an implantable device, in this instance a stent-graft, prepared for compaction in accordance with the present invention, tether lines having been applied to the device; Figure 2 is a cross-section view of the implantable device along line 2-2 of 10 Figure 1 at an initial enlarged cross-sectional dimension; Figure 3 is an isometric view of the device of Figure 1 being pulled through a funnel into a capture tube having an inner diameter (ID) approximately equal to an intermediate cross sectional dimension; Figure 4 is a cross-section view of the funnel, device, and capture tube of 15 Figure 3, with the device having been predominately compacted into the capture tube; Figure 5 is an isometric view of the capture tube having the implantable device contained therein; Figure 6 is a cross-section view of the capture tube and device along line 6-6 of Figure 5, showing the device at its intermediate cross sectional dimension; 20 Figure 7 is a schematic representation of a swaging die through which a capture tube and indwelling implantable device is compressed to a further reduced dimension; Figure 8 is a cross section view of the capture tube and indwelling implantable device being compressed by the swaging die of Figure 7, the implantable device being 25 shown in partial cut-away through the capture tube; Figure 9 is an isometric view of the capture tube having been compacted to a final cross sectional dimension with an indwelling implantable device; Figure 10 is an enlarged sectional view of the capture tube of Figure 9, showing the compacted implantable device in partial cut-away; 30 Figure 11 is a cross-section view of the capture tube and device along line 11 11 of Figure 9, showing the device at its final reduced dimension; Figure 12 is an isometric view of another embodiment of a capture tube of the present invention including a pre-determined break zone therein; Figure 13 is an enlarged partial isometric view of the capture tube of Figure 12, 35 showing the break zone; N:\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08 9 Figure 14 is an enlarged side view of a capture tube having a break zone, showing in cut-away an indwelling implantable device and illustrating the break zone as a further enlarged insert; Figure 15 is an isometric view of a capture tube having a break zone and an 5 indwelling compressed implantable device, the capture tube having been compressed to have an outer diameter (OD) approximately equal to a final compacted dimension of the implantable device, and a delivery sheath positioned over the capture tube, the delivery sheath having an inner diameter (ID) approximately equal to the outer diameter of the compressed capture tube; 10 Figure 16 is an isometric view of the capture tube and delivery sheath of Figrue 15, showing the capture tube having been separated at its break zone and each resulting half of the capture tube being removed from the sheath, leaving the implantable device contained at its final compacted dimension within the sheath; Figure 17 is a side cross section view of an implantable device of the prior art 15 being compacted through a funnel from an initial dimension to a final delivery dimension within a delivery tube having a dimension of "Z" and the forces F 1 and F 2 (resulting in overall force F 3 ) encountered in such compaction; Figure 18 is a side partial cut-away view of the implantable device and delivery tube of Figure 17 showing force F 2 encountered in deploying the device from the 20 delivery tube; Figure 19 is a side cross section view of an implantable device of the present invention being compacted through a funnel from an initial dimension to an intermediate dimension within a capture tube having a dimension of "X" and the forces
F
1 ' and F 2 ' (resulting in overall force F') encountered in such compaction; 25 Figure 20 is a side cross section view of an implantable device and capture tube of Figure 19 being further compacted from dimension "X" to final dimension "Z" in a swaging die; Figure 21 is a side partial cut-away view of the implantable device and capture tube of Figure 20 showing force F 2 encountered in deploying the device from the 30 capture tube; Figure 22 is a side cross section view of an implantable device of the present invention being compacted through a funnel from an initial dimension to an intermediate dimension within a capture tube (including a break zone), having a dimension of "X" and the forces F 1 ' and F 2 ' (resulting in overall force F 3 ') encountered 35 in such compaction; N,\Melbourne\Caaes\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed-doc 16/04/08 10 Figure 23 is a side cross section view of an implantable device and capture tube of Figure 22 being further compacted from dimension "X" to final dimension "Z" in a swaging die; Figure 24 is a side partial cut-away view of the implantable device and capture 5 tube of Figure 23 showing forces 1/2 F 2 encountered in deploying the device from the capture tube that is separated at the break zone; Figure 25 is an enlarged cross section view of an alternative swaging tapered die for use in the present invention, showing a capture tube and, in cut-away, a indwelling implantable device; 10 Figure 26 is a side view of an alternative compaction method of the present invention comprising an implantable medical device contained in a braided compaction tube; and Figure 27 is an isometric view of the implantable device and braided compaction tube of Figure 26 being drawn through a funnel into a capture tube. 15 DETAILED DESCRIPTION OF THE INVENTION The present invention provides an improved method for compacting an 20 implantable device to a very small introductory profile, and low-profile devices created through such method. As the terms "interventional" or "minimally invasive" devices or procedures are used herein they are intended to encompass any device or procedure whereby a medical treatment implement is delivered to a treatment site by use of wires and/or 25 tubes threaded through vessels or other body passageways accessed remotely. Minimally invasive implantable devices encompassed by the present invention may include those employed in: balloon angioplasty; thrombectomy; stent, graft, or stent graft placement; embolic filter device placement; remote diagnostic procedures, such as those employing fiber optic cameras, ultrasound monitoring, MRI monitoring, x-ray 30 monitoring, etc.; remote therapeutic procedures, such as those employing cutting blades, lasers, heat application, cold application, radiation, drug delivery, etc.; and any other similar devices or procedures now known or later developed. Currently such interventional procedures are employed in large and small blood vessels, in other vessels in the body, such as in the bile duct, as well as in the respiratory, digestive, N:\Melbourne\Cases\Patent\57000-57999\P7541.AU.1\Specio\P57S41.AU.1 speci as filed.doc 16/04/08 11 reproductive, and other body systems. As the term "patient" is used herein it is intended to encompass both humans and animals. The present invention achieves an extremely small introductory profile for implantable devices by partially "decoupling" the forces required to pull an implantable 5 through a funnel into a capture tube from the forces required to compact the device fully to its introductory profile. In its simplest form, the forces are decoupled by pulling an implantable device from a fully enlarged profile through a funnel and into a capture tube at an intermediate device profile. The intermediate profile is chosen so that the compaction and friction forces required to compact the device and place it in the 10 capture tube are less than the longitudinal strength of the device. In this manner the combined forces required to place the device into the capture tube are less than the longitudinal strength of the device so as to avoid any device damage in the initial pull down step. Once placed in the capture tube at the intermediate profile, the capture tube and device are then compressed down to a final delivery profile by swaging the 15 capture tube. Far greater compaction is possible using this process without applying any excessive longitudinal strain on the implantable device. Overall, this process separates into multiple steps the forces required to achieve full compaction. The process protects the integrity of the implantable device without requiring the implantable device to be more "robust" in order to withstand the 20 cumulative compaction and friction forces of transforming it from its fully enlarged profile to its fully compacted profile. In fact, the present invention can provide an implantable device at an introductory profile that it physically cannot achieve through compaction through a funnel alone. Further decoupling of forces in the present invention can be provided by using 25 a capture tube having one or more break zones therein. The capture tube can be split along the break zones into discrete capture tube segments that can each be separately removed from the device. Frictional forces applied to the implantable device during capture tube removal can thus be further reduced. Referring now to the drawings, Figures 1 through 11 illustrate process steps of 30 practicing one embodiment of the present invention, compacting an implantable device 30 from a fully enlarged deployed profile 32 to a fully compacted introductory profile 34. The term "profile" as it is used herein it is intended to encompass the overall general dimensions of an implantable device as viewed in cross section. "Profile" in the context of the present invention refers to the diameter of a device with circular cross N:\Melbourne\Caaes\Patent\57000-57999\P57541.AU.1\Specia\P57541.AU.1 apeci as filed-doc 16/04/08 12 section as well as dimensions of implantable devices having oblong, triangular, rectangular, or other regular or irregular cross-sectional shapes. Figures 1 and 2 show an implantable device 30 of the present invention. In this instance, the implantable device comprises an implantable endoprosthesis having a 5 stent 36 and a graft 38 component attached together. Endoprostheses of similar forms are commercially available from a number of sources. The endoprosthesis shown is illustrative of a variety of forms available from W. L. Gore & Associates, Inc., such as the VIABAHN TM tracheal endoprosthesis and the HEMOBAHN T M peripheral vascular endoprosthesis. 10 In order to compact this device through a funnel, tether lines 40 can be attached to one end of the implantable device 30, as is shown in Figure 1. As is shown in Figures 3 and 4, a funnel 42 is provided that has a wide opening 44 at one end approximately equal to the fully enlarged profile 32 and a narrow opening 46 at an opposite end approximately equal to an intermediate device profile 48. A restraining 15 member or capture tube 50 is aligned with the narrow opening 46. The tether lines 40 are threaded through the funnel 42 and the capture tube 50 and the implantable device 30 is then pulled down into the capture tube, as is shown in Figures 3 and 4. Once the implantable device 30 is fully pulled within the capture tube, the tether lines 40 can be removed. Figures 5 and 6 illustrate the implantable device 30 fully indwelling within the 20 capture tube 50 at the intermediate profile 48. A preferred funnel 42 for use with the present invention has one or more longitudinal ribs or "flutes" 52 provided therein. Such flutes 52 can aid in the folding and compacting of the stent 36 elements as the device 30 is pulled through the funnel, as is taught in International Publication No. WO 00/42948 to Vonesh et al. (based on 25 PCT Application PCT/US00/01 557), incorporated by reference. It has been found that the orderly folding of the endoprosthesis during compaction through a fluted funnel reduces the forces required to compact the device and also eases further compaction of the device in accordance with the present invention. The capture tube 50 for use with the present invention should have a number of 30 preferred properties. First, the tube should be formed from a material that is both stiff and strong enough to fully contain an indwelling self-expanding implantable device without at any time becoming deformed by the expansive forces of the device. Second, in order to undergo the further compaction of the tube and indwelling device in the swaging step of the present invention, the tube should be formed from a material 35 that will evenly compact from an inside diameter (ID) approximately equal to the N?\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specia\P57541.AU.1 apeci as filed.doc 16/04/08 13 intermediate profile 48 to an ID approximately equal to the fully compacted profile 34. The tube should undergo this transformation in ID without crimping or otherwise distorting the inner surface of the tube. Third, the tube should have a smooth inner surface so that the implantable device can be easily pulled into the tube during the 5 initial pull down through the funnel. Fourth, the tube should continue to have a smooth inner surface following swaging so that the tube can be readily separated from the compacted implantable device at the appropriate time. A suitable tube for use with the present invention may be formed from stainless steel, titanium, alloys, plastics or other suitable metals or polymers. Especially 10 preferred for use with the present invention is work-hardenable stainless steel alloy. The tube dimensions will vary depending upon the implantable device that is being processed. For an endoprosthesis with the following dimensions about 5.8 mm O.D. x about 50 mm. The tube is preferably dimensioned about 2.8 mm OD and about 2.5 mm ID and more preferably dimensioned about 2.08 mm OD and about 2.03 mm ID. 15 The preferred tube for use with the present invention comprises a tube of Series 304 stainless steel available from Microgroup, Inc., of Medway, MA, under part number 304H12XXTWX3.5 with 2.76 mm + 0.02 mm OD and 2.54 mm + 0.02 mm ID. Once the implantable device 30 is contained in the capture tube 50, the capture tube 50 can then be further reduced in dimensions through a swaging process. 20 "Swaging" as used in the present invention is intended to encompass any process by which the dimensions of the capture tube 50 can be further reduced. Swaging may be as simple as compressing the capture tube 50 by rolling it under pressure between a pair of plates, applying pressure to the tube by sequentially squeezing the tube using pliers or similar devices, or pulling the tube through a funnel-like device. Preferably, 25 swaging is accomplished by using a machine that can apply an even compression to the tube along its entire length, such as by using a Rotary Swaging Machine available from Torrington Swager Vaill End Forming Machinery, Inc. of Torrington, CTunder the designation No. 100. Swaging machines of this type use two or more swaging dies 52a, 52b, such as those shown in Figures 7 and 8. Alternatively, swaging can be 30 provided using an iris-based crimping device, such as those commercially available from Machine Solutions, Inc., Flagstaff, AZ, or similar compacting apparatus. As is illustrated in Figures 7 and 8, the capture tube 50 and indwelling implantable device 30 can be reduced from the intermediate profile 48 to the fully compacted profile 34 by passing the capture tube 50 through the swaging dies 52a, 35 52b while applying pressure to the dies. N:\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08 14 Once the capture tube 50 is fully compressed, the tube is both compacted and may be extended in length, as is shown in Figure 9. The indwelling implantable device 30 then assumes a tightly compressed fully compacted profile 34, as is shown in Figures 10 and 11. 5 Once the device is contained in the fully-compacted capture tube, the device can be packaged, sterilized, and maintained in the capture tube until the time of deployment, with the device being pushed out of the capture tube for ultimate deployment. Preferably, the device is alternatively transferred from the capture tube to other deployment apparatus for ultimate delivery to the patient. The deployment 10 apparatus may comprise a flexible catheter that receives the compacted device from the capture tube by direct transfer of the compacted device by pushing the compacted device from the capture tube into the catheter. Alternatively, transfer can be accomplished by placing the capture tube within a catheter with an ID approximately equal to the outer diameter of the compacted capture tube and then pushing the 15 compacted device out into the catheter for ultimate delivery. It should be evident that in this instance, the delivery profile of the implantable device will be slightly larger than the profile of the device as compacted in the capture tube. The device may optionally be attached to and reside upon the delivery catheter while being subject to the entire swaging process. 20 The deployment apparatus may also comprise other deployment devices, such as sheaths or tubes of material that can contain the device in its compacted profile until the time of delivery and deployment. For example, the compacted device of the present invention can be transferred to the delivery apparatus taught in US Patent 5,352,561 to Leopold et al., or the delivery apparatus taught in US Patent 6,224,627 to 25 Armstrong et al. A wide variety of other delivery apparatus that may be employed with the present invention, such as laced constraining and deploying apparatus (e.g., that disclosed in US Patent 5,919,225 to Lau et al. A further improvement of the present invention is illustrated in Figures 12 through 16. In this embodiment, the capture tube 50 comprises one having at least 30 one break zone 54 along its length. The break zone 54 may comprise any partition or weakening of the capture tube 50 at pre-determined places along its length that facilitates separating the tube into two or more segments 56a, 56b. In the embodiment shown, the break zone 54 comprises a score line that allows the capture tube 50 to be cleanly and easily broken in half. N,\Melbourne\Caaea\Patent\57000-57999\PS7541.AU.1\Specis\P5741.AU.1 speci as filed-doc 16/04/08 15 The break zone 54 should be strong enough to prevent the tube from twisting and breaking during swaging. After swaging, the break zone 54 should be weak enough to be readily broken in half. A suitable score line may be provided such as through machining or rolling. If appropriate materials are used, imparting work 5 hardening at the break zone during scoring and/or swaging may assist in the tube becoming very fragile in the scored area and aid in easy, clean, and consistent parting of the tube. By using one or more break zones 54, the fully compacted device can be more easily transferred to delivery apparatus by separating the capture tube into segments 10 56a, 56b that each can be separately removed from the implantable device 30. As is explained in greater detail below, this allows the capture tube 50 to be removed with a fraction of the frictional force required to separate a non-segmented capture tube. Figure 15 illustrates a fully compacted capture tube 50 having a break zone 54 provided therein placed within a delivery and deployment device 58, such as a catheter 15 or deployment sleeve. Once properly positioned within the deployment device 58, the capture tube 50 can be separated at the break zone 54 and each of the segments 56a, 56b can be separately removed, as is shown in Figure 16. Alternative break zones 54 for use with the present invention may include: chemical etched areas, heat treating of selected areas of the tube, perforations (e.g., 20 drilled, chemical mill, etched, or laser perforations), mechanical removal of tube material, or combinations thereof. Alternative means for transferring the fully compacted implantable device of the present invention into delivery apparatus may also include: pulling the device from the capture tube into the delivery apparatus (for instance, by leaving the tethers attached 25 or reattaching tether lines for the transfer, otherwise actuating mechanically, or actuating pneumatically (i.e., by using a vacuum)); pushing the device from the capture tube into the delivery apparatus (for instance, through mechanical, pneumatic, and/or hydraulic means); or combinations of both pushing and pulling. If the device is reduced and swaged on a delivery catheter, transfer can be accomplished by pulling 30 and/or pushing the delivery catheter. Figures 17 and 18 illustrate the interaction of forces acting upon a self expanding stent-graft during diametrical compaction and loading in a conventional loading process. Figures 19 through 24 illustrate the forces acting upon a self expanding stent-graft when loaded in accordance with the present invention. With 35 respect to all of Figures 17 through 24, the following convention is applied: Ns\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specis\PS7541.AU.1 speci as filed.doc 16/04/08 16
F
1 is the force required to radially compact the device;
F
2 is the friction encountered within the capture tube;
F
3 is the sum of F 1 and F 2 . 5 In Figure 17, a stent-graft 30 is depicted undergoing a conventional compaction and loading process in which the device is reduced in one step to the required introductory size of "Z." In this process, F 1 and F 2 are combined and result in F 3 . If F 3 is greater than the tensile break force of the stent-graft 30, the device will tear during the compacting process. Typically, minimally invasive devices tend to be relatively 10 delicate. Conversely, if one were to make a device more robust, the mass would likely increase, which would further complicate the compaction process and negatively impact ultimate delivery profiles. Figure 18 shows the stent-graft 30 fully compacted within a capture tube 50. To withdraw the stent-graft 30 from the capture tube 50 in this configuration will require a force equal to or greater than F 2 . 15 In Figure 19, the same size stent-graft 30 is depicted undergoing a compaction and loading process in which the device is reduced to an intermediate diameter of size "X". In this case the force required is also a sum of two forces F 1 ' and F 2 ', but this sum is a much lesser value than in conventional compaction process of Figure 17, since the work required to pack the device at the intermediate size "X" is less and the friction in 20 the deformable capture tube 50 is less. Once loaded into the deformable capture tube 50 at intermediate size "X", as is shown in Figure 20, the tube 50 and device 30 are compacted further to introductory size "Z" in a swaging machine 52. At introductory size "Z," as illustrated in Figure 21, the force required to withdraw the stent-graft 30 will be F 2 (the same as the force required to withdraw from the capture tube 50 illustrated 25 in Figure 18). As a result, an identical stent-graft 30 can be reduced to an identical profile in the process of Figures 19 through 21 with less longitudinal force applied to the device in the compaction process (that is, a force of F 3 ' instead of F 3 , wherein F 3 ' <
F
3 ). This significant reduction in overall required compaction force achieved by the present invention is the result of the "de-coupling" of the compaction force F 1 ' and the 30 capture tube frictional force F 2 ' from the full force required to achieve a fully compacted profile "Z." It has been determined that the de-coupling of these forces allows the present invention to compact identical medical devices to smaller delivery profiles than were previously possible by funnel reduction methods alone (that is, previously devices 35 would tear apart before reaching the small profiles possible with the present invention). Ns\Melbourne\Cases\Patent\57000-57999\P57541.AU.I\Specis\P57541.AU.1 apeci as filed.doc 16/04/08 17 Additionally, since the longitudinal strength of the devices is less of an issue in the compaction process, the de-coupling of these forces may allow devices to contain less mass than previous devices so that even smaller delivery profiles are now achievable. Figures 22 and 23 depict a stent-graft 30 undergoing the same process 5 illustrated in Figures 19 and 20 except that a deformable capture tube 50 is used having a break zone 54 provide therein. As is illustrated in Figure 24, a further significant force reduction is achieved by parting the deformable capture tube 50 after swaging and pulling each half off either end. In effect, this divides force F 2 by a factor of approximately 2 (that is, since each segment 56a, 56b is one-half the overall length 10 of tube 50, each segment will require approximately one-half the frictional force in order to separate each of the segments from the device 30). Thus, the use of a capture tube with one or more break zones therein can further reduce the frictional forces that the device will encounter during the device preparation process and again can allow devices to be used that have less mass than was previously possible. 15 Figure 25 illustrates an alternative swaging device for use with the present invention. In this instance, swaging is accomplished by drawing, pushing, or otherwise actuating the capture tube 50 through a reduction die 60, such as a funnel. The reduction die 60 should be constructed to allow the capture tube 50 to easily pass through it and provide a smooth transition from the intermediate profile to the fully 20 compacted profile. A reduction die is preferably constructed from hardened tool steel (e.g., D2 or A2 tool steel) or carbide, and may include a friction-reducing surface, such as PTFE and/or an applied lubricant. Further alternative means for swaging the capture tube 50 in accordance with the present invention may include compacting the device within a chuck, collet, iris, and/or tapered die device, and perhaps repeating 25 such compacting to achieve the desired compacted configuration along the length of the capture tube. Figures 26 and 27 show an alternative compaction method of the present invention. In this instance, a braided tube 62 is employed to surround the implantable device 30 and aid in actuating the device through a fluted funnel 42 into capture tube 30 50. The braided filaments 64 act as a "finger trap" to grip the entire implantable device 30 equally along its length during the draw down process. This gripping by the braid obviates the need to attach draw strings to the stent-graft itself, thus preventing damage to the stent-graft and eliminating a time consuming tether line attachment step in the process. The stent-graft is drawn through the die (by use of braided filament 35 tube) and into a deformable capture tube 50, as previously described. Once the device N,\Melbourne\Cases\Patent\57000-57999\PS7541.AU.1\Specia\P57541.AU.1 speci as filed.doc 16/04/08 18 30 is positioned within the capture tube 50, the braided tube 62 can be removed by pulling out the filaments 64 one or more at a time. The braided capture tube may be constructed from a wide variety of materials, including PTFE filaments, ePTFE filaments, nylon, KEVLAR@ polyamide, metal 5 filaments, or the like. The preferred braided capture tube comprises a polymer or metal filament with about 0.1 mm OD and having a braided construction comprising about 8 filaments braided in a one-over-one-under configuration, with about 20 to 25 picks per inch. 10 Without intending to limit the scope of the present invention, the following examples illustrate how the present invention may be made and used. Example 1 One embodiment of the present invention employing tether lines may be 15 practiced in the following manner. 1. Initial Profile Reduction Using Tether Lines 1. Using a Singer sewing needle and 200 denier RASTEX@ PTFE fiber 20 available from W.L. Gore and Associates, Inc., Elkton, MD, thread three 18 inch long tether lines through alternate end apexes on one end of a VIABAHNT'M endoprothesis available from W. L. Gore & Associates, Inc., Flagstaff, AZ; 2. Evenly tension the three tether lines and tie together with a common knot, as shown in Figure 1; 25 3. Form a work hardened circumferential score line approximately at the middle of a 304 stainless steel hypotube (2.76 mm ± 0.02 mm OD, 2.54 mm ± 0.02 ID) available from Microgroup, Medway MA; 3. Thread and draw the tether lines with attached endoprothesis through fluted funnel, as shown in Figure 3 and 4, into the hypotube attached to the end of the funnel; 30 4. Align the approximate midpoint of the endoprothesis at the circumferential score line; 5. Remove the hypotube from the funnel by removing funnel cap; 6. Cut and remove the tether lines from the captured endoprothesis. The endoprosthesis is now captured within the hypotube at an intermediate profile. 35 N:\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08 19 I1. Radial Compression 1. Employing a rotary swager with swage dies about 2.15 mm (Model 100 from Torrington Swager and Vaill End Forming Machinery Inc, Waterbury, CT), feed the 5 stainless steel hypotube and indwelling endoprosthesis into the swager. Swage the hypotube until at least half of it is completely reduced to a final profile; 2. Withdraw the hypotube from the swager while it continues to run; 3. Feed the opposite end of the hypotube into the swager until hypotube and indwelling endoprothesis are completely reduced to the final profile; 10 4. Wipe down the outside of reduced hypotube,with endoprothesis inside, using 70% IPA. Ill. Transfer to Delivery Apparatus 15 1. A break away constraint (BAC) delivery sleeve, such as that taught in US Patent 5,352,561 to Leopold et al., is mounted over the reduced hypotube until leading edge of the BAC is even with the worked hardened circumferential scored line; 2. The reduced hypotube is broken at the scored line; 3. Continue loading BAC over reduced hypotube until midpoint of the BAC is 20 located over the broken scored line; 4. Separate the reduced hypotube at broken scored line capturing the endoprothesis in the BAC; 5. Ensure that the endoprothesis is entirely captured by and properly centered in the BAC. 25 Example 2: A SECOND EMBODIMENT OF THE PRESENT INVENTION MAY BE CONSTRUCTED IN THE FOLLOWING MANNER. 30 1. INITIAL PROFILE REDUCTION USING BRAID 1. Cut approximately a four-inch segment of nylon eight-filament braid from a construction core, such as that available from ViaMed Corporation, South Easton, MA, with a construction of one over, one under diamond pattern, 25 picks/inch; N:\Melbourne\CaseB\Patent\57000-57999\P57541.AU.1\Speci\P7541.AU.1 speci as filed.doc 16/04/08 20 2. Axially compress the braid segment and load over a VIABAHNTM endoprothesis by sliding compressed braid segment onto endoprothesis. Pull light tension on braid. The endoprothesis should be off-centered within the braid length; 3. Applying tension, draw the endoprothesis through the fluted funnel shown in 5 Figures 3 and 4 into a 2.76 mm ± 0.02 mm OD, 2.54 mm ± 0.02 ID 304 stainless steel hypotube that includes a circumferntial score line. The hypotube should be mounted on the end of the funnel; 4. Locate the midpoint of the endoprothesis at the circumferential score line in the middle of the hypotube; 10 5. Remove the hypotube from the funnel by removing the funnel cap. 6. Remove each filament of braid one at a time by hand until all the filaments have been removed. II. Transfer to Delivery Apparatus 15 1. Employing a rotary swager with swage dies about 2.15 mm (Model 100 from Torrington Swager and Vaill End Forming Machinery Inc, Waterbury, CT), feed the stainless steel hypotube and indwelling endoprosthesis into the swager. Swage the hypotube until at least half of it is completely reduced to a final profile; 20 2. Withdraw the hypotube from the swager while it continues to run; 3. Feed the opposite end of the hypotube into the swager until hypotube and indwelling endoprothesis are completely reduced to the final profile; 4. Wipe down the outside of reduced hypotube,with endoprothesis inside, using 70% IPA. 25 Ill. Transfer to Delivery Apparatus 1. A break away constraint (BAC) delivery sleeve, such as that taught in US Patent 5,352,561 to Leopold et al., is mounted over the reduced hypotube until leading 30 edge of the BAC is even with the worked hardened circumferential scored line; 2. The reduced hypotube is broken at the scored line; 3. Continue loading BAC over reduced hypotube until midpoint of the BAC is located over the broken scored line; 4. Separate the reduced hypotube at broken scored line capturing the 35 endoprothesis in the BAC; Nc\Melbourne\Cases\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08 21 5. Ensure that the endoprothesis is entirely captured by and properly centered in the BAC. Example 3: 5 A third embodiment of the present invention may be practiced in the following manner. 1. Initial Profile Reduction Using Tether Lines 10 1. Using a Singer sewing needle and 200 denier RASTEX@ PTFE fiber available from W.L. Gore and Associates, Inc., Elkton, MD, thread three 18 inch long tether lines through alternate end apexes on one end of a VIABAHNTM endoprothesis available from W. L. Gore & Associates, Inc., Flagstaff, AZ; 2. Evenly tension the three tether lines and tie together with a common knot, 15 as shown in Figure 1; 3. Form a work hardened circumferential score line approximately at the middle of a 304 stainless steel hypotube (2.76 mm ± 0.02 mm OD, 2.54 mm ± 0.02 ID) available from Microgroup, Medway MA; 3. Thread and draw the tether lines with attached endoprothesis through fluted 20 funnel, as shown in Figure 3 and 4, into the hypotube attached to the end of the funnel; 4. Align the approximate midpoint of the endoprothesis at the circumferential score line; 5. Remove the hypotube from the funnel by removing funnel cap; 6. Cut and remove the tether lines from the captured endoprothesis. The 25 endoprosthesis is now captured within the hypotube at an intermediate profile. II. Flat Die Reduction of Hypotube 1. Crimp 12.7 mm of one end of the hypotube. Ensure not to crimp the 30 indwelling endoprothesis; 2. Place a "Tuning Fork" flat die holder, made by KPG Machine, Danielson, CT, into the bottom jaws of a Model #5564 INSTRON tensile tester, available from Instron Corp., Canton, MA; 3. Use a fully hardened D2 tool steel 12.7 mm x 12.7 mm x 3.175 mm flat 35 tapered die with a 2.15 mm reducing tapered hole bore out at its center, also available N:\Melbourne\Cases\Patent\57000-S7999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08 22 from KPG Machine. Place the tapered die into holder, with the larger diameter of the tapered hole facing down; 4. Fit the crimped end of the hypotube through the larger diameter of the tapered hole of the flat tapered die; 5 5. Close the top jaws of INSTRON tensile tester onto the 3.175 mm crimped portion of hypotube; 6. Press the "UP" button on the tensile tester to begin drawing the 304 stainless steel hypotube through the flat tapered die. The drawing process is complete when the hypotube is completely reduced; 10 7. Open the top jaw and remove the hypotube; 8. Wipe down the outside of reduced hypotube,with endoprothesis inside, using 70% IPA. Ill. Transfer to Delivery Apparatus 15 1. A break away constraint (BAC) delivery sleeve, such as that taught in US Patent 5,352,561 to Leopold et al., is mounted over the reduced hypotube until leading edge of the BAC is even with the worked hardened circumferential scored line; 2. The reduced hypotube is broken at the scored line; 3. Continue loading BAC over reduced hypotube until midpoint of the BAC is 20 located over the broken scored line; 4. Separate the reduced hypotube at broken scored line capturing the endoprothesis in the BAC; 5. Ensure that the endoprothesis is entirely captured by and properly centered in the BAC. 25 While particular embodiments of the present invention have been illustrated and described herein, the present invention should not be limited to such illustrations and descriptions. It should be apparent that changes and modifications may be incorporated and embodied as part of the present invention within the scope of the 30 following claims. In the claims which follow and in the preceding description of the invention, except where the context requires otherwise due to express language or necessary implication, the word "comprise" or variations such as "comprises" or "comprising" is used in an inclusive sense, i.e. to specify the presence of the stated features but not to N:\Melbourne\Cases\Patent\57000-57999\PS7541.AU.1\Specis\P57541.AU.1 epeci as filed.doc 16/04/08 23 preclude the presence or addition of further features in various embodiments of the invention. It is to be understood that, if any prior art publication is referred to herein, such reference does not constitute an admission that the publication forms a part of the 5 common general knowledge in the art, in Australia or any other country. N:\Melbourne\Casea\Patent\57000-57999\P57541.AU.1\Specis\P57541.AU.1 speci as filed.doc 16/04/08
Claims (5)
1. A capture tube and indwelling stent assembly, the stent being self-expanding to an expanded diameter and having a 5 longitudinal tensile strength, and the capture tube being deformable and having an expanded diameter that is less than the expanded diameter of the stent, wherein the assembly can be swaged to a compacted diameter that is less than the expanded diameter of the capture tube, 10 wherein, when the assembly is compacted to the compacted diameter, the stent can be removed from the capture tube by application of a tensile force on the stent that is less than the longitudinal tensile strength, and wherein the longitudinal tensile strength of the stent is less than the tensile force required to directly swage the stent to the compacted diameter. 15
2. A capture tube and indwelling stent assembly according to claim 1, wherein the compacted diameter of the assembly is smaller than a diameter that can be achieved by pulling the stent alone through a funnel because the longitudinal tensile strength of the stent is less than the force required to compact the stent alone through the funnel 20 to the compacted diameter.
3. A capture tube and indwelling stent assembly according to either claim 1 or 2, wherein the stent further includes a graft component attached thereto. 25
4. A capture tube and indwelling stent assembly according to any one of claims 1 to 3, wherein the stent does not significantly change in length between its expanded diameter and the compacted diameter.
5. A capture tube and indwelling stent assembly substantially as herein described 30 with reference to the accompanying figures. 874926_2 (GHMatters) 16/04/08
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008201695A AU2008201695B2 (en) | 2003-01-17 | 2008-04-16 | Compacted implantable medical devices and method of compacting such devices |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/346,822 | 2003-01-17 | ||
AU2004207461A AU2004207461B2 (en) | 2003-01-17 | 2004-01-14 | Compacted implantable medical devices and method of compacting such devices |
AU2008201695A AU2008201695B2 (en) | 2003-01-17 | 2008-04-16 | Compacted implantable medical devices and method of compacting such devices |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004207461A Division AU2004207461B2 (en) | 2003-01-17 | 2004-01-14 | Compacted implantable medical devices and method of compacting such devices |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2008201695A1 AU2008201695A1 (en) | 2008-05-08 |
AU2008201695B2 true AU2008201695B2 (en) | 2009-10-22 |
Family
ID=39412289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2008201695A Expired AU2008201695B2 (en) | 2003-01-17 | 2008-04-16 | Compacted implantable medical devices and method of compacting such devices |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2008201695B2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5662713A (en) * | 1991-10-09 | 1997-09-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
US6132458A (en) * | 1998-05-15 | 2000-10-17 | American Medical Systems, Inc. | Method and device for loading a stent |
US20010027339A1 (en) * | 1997-09-24 | 2001-10-04 | Boatman Scott E. | Radially expandable stent |
US6520983B1 (en) * | 1998-03-31 | 2003-02-18 | Scimed Life Systems, Inc. | Stent delivery system |
US6702845B1 (en) * | 2003-01-17 | 2004-03-09 | Gore Enterprise Holdings, Inc. | Compacted implantable medical devices and method of compacting such devices |
-
2008
- 2008-04-16 AU AU2008201695A patent/AU2008201695B2/en not_active Expired
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5662713A (en) * | 1991-10-09 | 1997-09-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
US20010027339A1 (en) * | 1997-09-24 | 2001-10-04 | Boatman Scott E. | Radially expandable stent |
US6520983B1 (en) * | 1998-03-31 | 2003-02-18 | Scimed Life Systems, Inc. | Stent delivery system |
US6132458A (en) * | 1998-05-15 | 2000-10-17 | American Medical Systems, Inc. | Method and device for loading a stent |
US6702845B1 (en) * | 2003-01-17 | 2004-03-09 | Gore Enterprise Holdings, Inc. | Compacted implantable medical devices and method of compacting such devices |
Also Published As
Publication number | Publication date |
---|---|
AU2008201695A1 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6702845B1 (en) | Compacted implantable medical devices and method of compacting such devices | |
US20230149035A1 (en) | Devices and methods for aspiration of thrombus | |
US5800519A (en) | Tubular medical prosthesis for use in a body lumen | |
CN101299975B (en) | Twist-down implant delivery technologies | |
US9572699B2 (en) | Sheaths used with polymer scaffolds | |
CA2734680C (en) | Method of loading a stent into a sheath | |
EP1073384B1 (en) | Low profile stent and graft combination | |
US5725519A (en) | Stent loading device for a balloon catheter | |
US8048139B2 (en) | Reversible applicator for an intraluminal endoprosthesis | |
US9687370B2 (en) | Method of loading a stent into a sheath | |
JP2005533557A (en) | Intraluminal dilation system | |
CA2328863A1 (en) | Stent deployment device and method for deploying a stent | |
US8066756B2 (en) | Containment sleeve and deployment device | |
AU2008201695B2 (en) | Compacted implantable medical devices and method of compacting such devices | |
US20100222862A1 (en) | Stent, Stent Graft and Other Implantable Assemblies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
PC | Assignment registered |
Owner name: W. L. GORE & ASSOCIATES, INC. Free format text: FORMER OWNER WAS: GORE ENTERPRISE HOLDINGS, INC. |
|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |